PortfoliosLab logoPortfoliosLab logo
MU vs. CRVS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MU vs. CRVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Micron Technology, Inc. (MU) and Corvus Pharmaceuticals, Inc. (CRVS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MU achieves a 232.74% return, which is significantly higher than CRVS's 44.81% return. Over the past 10 years, MU has outperformed CRVS with an annualized return of 55.03%, while CRVS has yielded a comparatively lower -1.39% annualized return.


MU

1D
9.87%
1M
27.11%
YTD
232.74%
6M
284.77%
1Y
776.52%
3Y*
144.94%
5Y*
65.39%
10Y*
55.03%

CRVS

1D
0.27%
1M
-28.30%
YTD
44.81%
6M
30.26%
1Y
185.17%
3Y*
46.04%
5Y*
31.93%
10Y*
-1.39%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MU vs. CRVS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MU
Micron Technology, Inc.
232.74%240.24%-0.96%71.93%-45.93%24.21%39.79%69.49%-22.84%87.59%
CRVS
Corvus Pharmaceuticals, Inc.
44.81%43.93%203.98%107.06%-64.73%-32.30%-34.56%48.23%-64.58%-27.55%

Correlation

The correlation between MU and CRVS is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.20

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (10Y)
Calculated over the trailing 10-year period

0.20

Correlation (All Time)
Calculated using the full available price history since Mar 24, 2016

0.19

Fundamentals

Market Cap

MU:

$1.08T

CRVS:

$1.00B

EPS

MU:

$21.26

CRVS:

-$0.53

PB Ratio

MU:

14.94

CRVS:

4.17

Total Revenue (TTM)

MU:

$58.12B

CRVS:

$0.00

Gross Profit (TTM)

MU:

$33.96B

CRVS:

-$26.00K

EBITDA (TTM)

MU:

$25.99B

CRVS:

-$47.43M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MU vs. CRVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MU
MU Risk / Return Rank: 9999
Overall Rank
MU Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
MU Sortino Ratio Rank: 9999
Sortino Ratio Rank
MU Omega Ratio Rank: 9898
Omega Ratio Rank
MU Calmar Ratio Rank: 100100
Calmar Ratio Rank
MU Martin Ratio Rank: 100100
Martin Ratio Rank

CRVS
CRVS Risk / Return Rank: 8686
Overall Rank
CRVS Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
CRVS Sortino Ratio Rank: 9696
Sortino Ratio Rank
CRVS Omega Ratio Rank: 9393
Omega Ratio Rank
CRVS Calmar Ratio Rank: 8585
Calmar Ratio Rank
CRVS Martin Ratio Rank: 8383
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MU vs. CRVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Micron Technology, Inc. (MU) and Corvus Pharmaceuticals, Inc. (CRVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MUCRVSDifference
Sharpe ratioReturn per unit of total volatility

+10.41

Sortino ratioReturn per unit of downside risk

+2.02

Omega ratioGain probability vs. loss probability

1.81

1.48

+0.33

Calmar ratioReturn relative to maximum drawdown

25.90

3.30

+22.60

Martin ratioReturn relative to average drawdown

100.37

7.42

+92.95

MU vs. CRVS - Sharpe Ratio Comparison

The current MU Sharpe Ratio is 11.44, which is higher than the CRVS Sharpe Ratio of 1.03. The chart below compares the historical Sharpe Ratios of MU and CRVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


MUCRVSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

11.44

1.03

+10.41

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.24

0.24

+1.00

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

1.11

-0.01

+1.12

Sharpe Ratio (All Time)

Calculated using the full available price history

0.31

-0.02

+0.33

Drawdowns

MU vs. CRVS - Drawdown Comparison

The maximum MU drawdown since its inception was -98.25%, roughly equal to the maximum CRVS drawdown of -96.97%. Use the drawdown chart below to compare losses from any high point for MU and CRVS.


Loading charts...

Drawdown Indicators


MUCRVSDifference

Max Drawdown

Largest peak-to-trough decline

-98.25%

-96.97%

-1.28%

Max Drawdown (1Y)

Largest decline over 1 year

-30.28%

-56.43%

+26.15%

Max Drawdown (3Y)

Largest decline over 3 years

-57.63%

-70.50%

+12.87%

Max Drawdown (5Y)

Largest decline over 5 years

-57.63%

-92.40%

+34.77%

Max Drawdown (10Y)

Largest decline over 10 years

-57.63%

-96.97%

+39.34%

Current Drawdown

Current decline from peak

-12.07%

-56.31%

+44.24%

Average Drawdown

Average peak-to-trough decline

-58.19%

-69.32%

+11.13%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.80%

25.07%

-17.27%

Volatility

MU vs. CRVS - Volatility Comparison

Micron Technology, Inc. (MU) has a higher volatility of 34.16% compared to Corvus Pharmaceuticals, Inc. (CRVS) at 23.70%. This indicates that MU's price experiences larger fluctuations and is considered to be riskier than CRVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MUCRVSDifference

Volatility (1M)

Calculated over the trailing 1-month period

34.16%

23.70%

+10.46%

Volatility (6M)

Calculated over the trailing 6-month period

56.74%

111.87%

-55.13%

Volatility (1Y)

Calculated over the trailing 1-year period

68.70%

181.10%

-112.40%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

52.91%

131.06%

-78.15%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.99%

111.16%

-61.17%

Dividends

MU vs. CRVS - Dividend Comparison

MU's dividend yield for the trailing twelve months is around 0.05%, while CRVS has not paid dividends to shareholders.


PositionTTM20252024202320222021
CRVS
Corvus Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%
MU
Micron Technology, Inc.
0.05%0.16%0.55%0.54%0.89%0.21%

Financials

MU vs. CRVS - Financials Comparison

This section allows you to compare key financial metrics between Micron Technology, Inc. and Corvus Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
23.86B
0
(MU) Total Revenue
(CRVS) Total Revenue
Values in USD except per share items

Frequently Asked Questions


MU and CRVS have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MU has higher volatility (34.16%) compared to CRVS (23.70%). In terms of maximum drawdown, MU dropped -98.25% vs CRVS's -96.97%.

MU currently has the higher Sharpe Ratio (11.44 vs 1.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MU and CRVS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer